...
首页> 外文期刊>Diagnostic and therapeutic endoscopy >Endoscopic Treatment of Vesicoureteral Reflux in Children with Dextranomer/Hyaluronic Acid—A Single Surgeon's 6-Year Experience
【24h】

Endoscopic Treatment of Vesicoureteral Reflux in Children with Dextranomer/Hyaluronic Acid—A Single Surgeon's 6-Year Experience

机译:内窥镜治疗右旋糖酐/透明质酸患儿的输尿管反流-一个单一的外科医生六年的经验。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Endoscopic treatment for vesicoureteral reflux (VUR) has become an established alternative to long-term antibiotic prophylaxis and ureteral reimplantation. We present the outcome of endoscopic treatment with dextranomer/hyaluronic acid copolymer (Deflux) for VUR in children by a single surgeon at our institute from October 2003 to October 2009. We reviewed the cases of 150 patients (total 239 ureters), 56 girls (37%) and 94 boys (63%), with a mean age of 2.2 years and a median followup of 2.5 years (range 3–68 months). Among the 239 ureters treated, 67.4% (161/239) were cured with a single injection, and a second and third injection raised the cure rate to 86.6% (207/239) and 88.3% (211/239), respectively. None had postoperative ureteral obstruction.
机译:内镜治疗膀胱输尿管反流(VUR)已成为长期预防和输尿管再造的公认选择。我们介绍了2003年10月至2009年10月由我院一名外科医生用右旋糖酐/透明质酸共聚物(Deflux)对儿童进行VUR的内镜治疗的结果。我们回顾了150例患者(总共239例输尿管),56例女孩( 37%)和94名男孩(63%),平均年龄为2.2岁,中位随访时间为2.5年(范围3-68个月)。在经治疗的239例输尿管中,单次注射治愈67.4%(161/239),第二次和第三次注射分别将治愈率提高到86.6%(207/239)和88.3%(211/239)。术后均无输尿管梗阻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号